Calendar Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

End-of-day quote Taiwan S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
42.2 TWD -3.10% Intraday chart for Tanvex BioPharma, Inc. -1.97% -35.18%

Chart calendar Tanvex BioPharma, Inc.

13f968a78785c6a82aa013f.tjSW_IaEpJeUbdU8FXRuG9t9i3QJuz8GIG-UwFIy0Cw.00bUlsDK5sGhGZFqIxsBaI8i0xE7j1UyFiL3kQBxgmj0cfqNxf2cz8EsmA~937ff0bc1554bf284918a653a3ca95ac

Upcoming events on Tanvex BioPharma, Inc.

2024-06-18 Annual General Meeting
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-04 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Tanvex BioPharma, Inc.

2024-05-06 Q1 2024 Earnings Release
2024-04-08 March 2024 Sales and Revenue Release
2024-04-01 02:30 MasterLink Securities Investor Conference
2024-03-14 03:29 Q4 2023 Earnings Release
2024-03-06 02:53 February 2024 Sales and Revenue Release
2024-02-07 01:46 January 2024 Sales and Revenue Release
2024-01-10 01:06 December 2023 Sales and Revenue Release
2023-12-08 01:25 November 2023 Sales and Revenue Release
2023-11-13 03:54 Q3 2023 Earnings Release
2023-11-08 03:43 October 2023 Sales and Revenue Release
2023-10-05 01:42 September 2023 Sales and Revenue Release
2023-05-12 03:00 Masterlink Securities's Investor Conference
2023-04-10 04:39 March 2023 Sales and Revenue Release
2023-03-09 04:34 February 2023 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million TWD
Released
Forecast
Spread
0,00
0,00
-
0,30
0,00
-
5,41
0,00
-
EBITDA
Million TWD
Released
Forecast
Spread
-2 112
-2 193
3.68%
-1 879
-1 991
5.62%
-1 356
-1 713
20.86%
EBIT
Million TWD
Released
Forecast
Spread
-2 328
-2 345
0.72%
-2 100
-2 198
4.48%
-1 599
-1 941
17.61%
Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-2 274
-2 281
0.3%
-2 104
-2 177
3.34%
-1 543
-1 885
18.13%
Net income
Million TWD
Released
Forecast
Spread
-2 274
-2 281
0.3%
-2 104
-2 177
3.34%
-1 543
-1 885
18.13%
EPS
TWD
Released
Forecast
Spread
-27,8
-27,2
-2.21%
-23,5
-24,7
4.85%
-14,2
-18,1
21.65%
Announcement Date26/03/2029/03/2128/03/22

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3
Net sales
Million TWD
Released
Forecast
Spread



3,04
3,00
1.47%
8,33
3,00
177.67%
EBIT
Million TWD
Released
Forecast
Spread



-418
-329
-26.97%
-392
-338
-15.85%
Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread



-427
-327
-30.59%
-404
-336
-20.3%
Net income
Million TWD
Released
Forecast
Spread
-332


-427
-327
-30.6%
-404
-336
-20.3%
EPS
TWD
Released
Forecast
Spread
-2,82


-3,63
-2,79
-30.11%
-3,45
-2,85
-21.05%
Announcement Date13/05/2230/08/2214/11/22

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6541 Stock
  4. Calendar Tanvex BioPharma, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW